SE9804063D0 - Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells - Google Patents

Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells

Info

Publication number: SE9804063D0
Authority: SE; Sweden
Prior art keywords: cells; stem cells; progenitor cells; igf; functional analogue
Prior art date: 1998-11-25

Application number

SE9804063A

Other languages

English (en)

Other versions

SE9804063L (sv

Inventor

Peter Eriksson

Maria Aaberg

Original Assignee

Peter Eriksson

Maria Aaberg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-25

Filing date

1998-11-25

Publication date

1998-11-25

1998-11-25 Application filed by Peter Eriksson, Maria Aaberg filed Critical Peter Eriksson

1998-11-25 Priority to SE9804063A priority Critical patent/SE9804063L/sv

1998-11-25 Publication of SE9804063D0 publication Critical patent/SE9804063D0/sv

2000-07-17 Publication of SE9804063L publication Critical patent/SE9804063L/sv

Links

238000000034 method Methods 0.000 title abstract 4
210000005155 neural progenitor cell Anatomy 0.000 title abstract 4
210000001178 neural stem cell Anatomy 0.000 title abstract 4
229940126601 medicinal product Drugs 0.000 title 1
210000000130 stem cell Anatomy 0.000 abstract 8
210000001130 astrocyte Anatomy 0.000 abstract 4
230000001939 inductive effect Effects 0.000 abstract 4
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 4
210000002569 neuron Anatomy 0.000 abstract 4
210000004248 oligodendroglia Anatomy 0.000 abstract 4
239000000126 substance Substances 0.000 abstract 4
108090000623 proteins and genes Proteins 0.000 abstract 3
102000004877 Insulin Human genes 0.000 abstract 2
108090001061 Insulin Proteins 0.000 abstract 2
230000002159 abnormal effect Effects 0.000 abstract 2
210000004027 cell Anatomy 0.000 abstract 2
210000003169 central nervous system Anatomy 0.000 abstract 2
BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 abstract 2
239000003102 growth factor Substances 0.000 abstract 2
229940125396 insulin Drugs 0.000 abstract 2
210000001428 peripheral nervous system Anatomy 0.000 abstract 2
239000000825 pharmaceutical preparation Substances 0.000 abstract 2
229940127557 pharmaceutical product Drugs 0.000 abstract 2
208000016021 phenotype Diseases 0.000 abstract 2
238000000338 in vitro Methods 0.000 abstract 1
210000000653 nervous system Anatomy 0.000 abstract 1
210000003061 neural cell Anatomy 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Cell Biology (AREA)
General Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Diabetes (AREA)
Molecular Biology (AREA)
Endocrinology (AREA)
Microbiology (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

SE9804063A 1998-11-25 1998-11-25 Medicinsk produkt och förfarande för behandling av tillstånd som påverkar neurala stamceller eller progenitorceller SE9804063L (sv)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
SE9804063A SE9804063L (sv)	1998-11-25	1998-11-25	Medicinsk produkt och förfarande för behandling av tillstånd som påverkar neurala stamceller eller progenitorceller

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9804063A SE9804063L (sv)	1998-11-25	1998-11-25	Medicinsk produkt och förfarande för behandling av tillstånd som påverkar neurala stamceller eller progenitorceller

Publications (2)

Publication Number	Publication Date
SE9804063D0 true SE9804063D0 (sv)	1998-11-25
SE9804063L SE9804063L (sv)	2000-07-17

Family

ID=20413428

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE9804063A SE9804063L (sv)	1998-11-25	1998-11-25	Medicinsk produkt och förfarande för behandling av tillstånd som påverkar neurala stamceller eller progenitorceller

Country Status (1)

Country	Link
SE (1)	SE9804063L (sv)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN116159136A (zh) *	2022-12-22	2023-05-26	江南大学	一种手性纳米材料在制备诱导神经元细胞产生igf-1的药物中的应用

1998
- 1998-11-25 SE SE9804063A patent/SE9804063L/sv not_active Application Discontinuation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN116159136A (zh) *	2022-12-22	2023-05-26	江南大学	一种手性纳米材料在制备诱导神经元细胞产生igf-1的药物中的应用
CN116159136B (zh) *	2022-12-22	2023-10-10	江南大学	一种手性纳米材料在制备诱导神经元细胞产生igf-1的药物中的应用

Also Published As

Publication number	Publication date
SE9804063L (sv)	2000-07-17

Similar Documents

Publication	Publication Date	Title
Lin et al.	1989	A critical role of the posterior hypothalamus in the mechanisms of wakefulness determined by microinjection of muscimol in freely moving cats
WO2000030675A3 (en)	2000-08-17	Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
Chen et al.	2001	BDNF enhances retinal ganglion cell survival in cats with optic nerve damage
Jiao et al.	1993	Long-term correction of rat model of Parkinson's disease by gene therapy
Gao et al.	2012	Hypoxic preconditioning attenuates global cerebral ischemic injury following asphyxial cardiac arrest through regulation of delta opioid receptor system
Anisman et al.	1998	Differential effects of interleukin (IL)-1β, IL-2 and IL-6 on responding for rewarding lateral hypothalamic stimulation
Haroutunian et al.	1986	Partial reversal of lesion-induced deficits in cortical cholinergic markers by nerve growth factor
Bonmann et al.	1997	The dominant role of exogenous or endogenous interleukin-1 beta on expression and activity of inducible nitric oxide synthase in rat microvascular brain endothelial cells
HUP0001237A2 (hu)	2000-08-28	Módszerek érrendszeri rendellenességek gyógykezeléséhez
Eggert et al.	1999	Glial cell line-derived neurotrophic factor protects dopaminergic neurons from 6-hydroxydopamine toxicity in vitro
Sánchez‐Mendoza et al.	2013	Could neurotransmitters influence neurogenesis and neurorepair after stroke?
CA2658564A1 (en)	2008-02-21	Treatment of ocular diseases
Beecher et al.	2018	Factors that modulate olfactory dysfunction
CN110448598A (zh)	2019-11-15	一种医用水溶性大麻二酚cbd制剂配方
Zhang et al.	2018	Interferon-γ promotes neuronal repair by transplanted neural stem cells in ischemic rats
Katner et al.	2002	Neuropeptide Y administration into the amygdala does not affect ethanol consumption
CN101333542A (zh)	2008-12-31	基因修饰的间充质干细胞眼内移植修复视网膜损伤的方法
US6617311B1 (en)	2003-09-09	Regulation of tyrosine hydroxylase
Darracq et al.	1996	Effect of strychnine on rat locus coeruleus neurones during sleep and wakefulness
Freye et al.	1981	Fentanyl in the fourth cerebral ventricle causes respiratory depression in the anesthetized but not in the awake dog
Liu et al.	1997	Basic fibroblast growth factor-induced seizures in rats
Dong-Ruyl et al.	1998	Tryptophan and its metabolite, kynurenine, stimulate expression of nerve growth factor in cultured mouse astroglial cells
SE9804063D0 (sv)	1998-11-25	Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
Koyama et al.	2005	Endothelins stimulate the expression of neurotrophin-3 in rat brain and rat cultured astrocytes
Xu et al.	2000	Effects of galanin on wide-dynamic range neuron activity in the spinal dorsal horn of rats with sciatic nerve ligation

Legal Events

Date	Code	Title	Description
2004-05-18	NAV	Patent application has lapsed